5GZ — HGH Holdings Income Statement
0.000.00%
Last trade - 00:00
- SG$21.37m
- SG$18.27m
- SG$20.03m
- 30
- 62
- 58
- 48
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 23.9 | 11.7 | 20.1 | 21.6 | 20 |
Cost of Revenue | |||||
Gross Profit | 9.01 | 3.65 | 4.55 | 3.84 | 3.78 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 25.7 | 15.8 | 22.5 | 23.4 | 20.6 |
Operating Profit | -1.75 | -4.1 | -2.39 | -1.8 | -0.566 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.89 | -4.81 | -3.02 | -1.78 | -0.606 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.93 | -4.25 | -2.29 | -1.51 | -0.324 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -5.9 | -4.24 | -2.27 | -1.5 | -0.307 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.9 | -4.24 | -2.27 | -1.5 | -0.307 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.003 | -0.002 | -0.001 | -0.001 | -0 |